Welcome to our PSYRES foundation for psychedelic research website.
As the name suggests, the foundation’s mission is to secure financial support for Czech scientific projects and workplaces which focus on innovative treatment procedures of mental illnesses. Naturally, psychedelic-assisted psychotherapy belongs to this category.
Although it is not very publicly known, psychedelic research has a long tradition in our country.
J. E. Purkyně experimented with nutmeg and deadly nightshade as early as in the 19th century. Prior to the 2nd World War, Dr Svetozar Nevole published his study about mescaline and its effect on a person’s mental activity. Later, psychoactive substances were experimented on by Dr Stanislav Grof, Dr Jiří Roubíček, and the research group of Dr Miloš Vojtěchovský which was already focusing on their psychotherapeutic use.
Even though the studies of the therapeutic potential of psychedelics was internationally stopped in the 1970s, with the new millennium we are experiencing a renaissance of promising research.
The goal of our foundation is to support the research and studies of psychedelic substances, their use in pharmacology, psychology, addictology, and psychiatry. With our activities, we help to prepare and realize clinical studies, analysis, and educational events.
We collaborate with doctors, therapists, and researchers who dive deep into the potentials of altering one’s consciousness.
We are partnered with important Czech and international institutions.
Sympathizers of the promising Czech psychedelic research are actively being sought out not only philanthropists, but in the public community as well.
We are convinced that the utilization of psychedelics in clinical medicine can bring a significant change in the way we treat mental illnesses, and that it can secure new knowledge about the essence of human consciousness.
With your help, we will reach these goals!
Addiction specialist and coordinator of research projects at the National Institute of Mental Health (NIMH). In the past, she was an employee of the Secretariat of the Government Council for Drug Policy Coordination where she took part in organizing national conferences with addictology themes. Since 2016, she has been a part of the local team of organizers of the European Conference on Mental Health (ECMH).
Addiction specialist, student of the Ph.D. programme at the Faculty of Arts and the Department of Addictology, Charles University, where she focuses on the ritual use of psychedelics in the Czech context. She is the co-founder of CZEPS (Czech Psychedelic Society), organizer of events with psychedelic themes, and media representative of psychedelic research at the National Institute of Mental Health (NIMH).
Neuroscientist, psychiatrist, psychotherapist, and the chief of the Department of Psychiatry and Medical Psychology 3FM CU. His field of research at the 3FM CU and in the National Institute on Mental Health (NIMH), is the study of the therapeutic effect of psychedelics, the theory of consciousness, the study of schizophrenia, and the use of neuromonitoring methods. He is a co-founder of the Psyon clinic.
Psychiatrist and neuroscientist. His speciality has been the effects of psychedelics and other psychoactive substances. He is the head of the Psychedelics Research Centre at the National Institute on Mental Health (NIMH). His teams’ research projects range from a wide selection of cell cultures to behavioural studies of animals to studies made on healthy volunteers and depressed patients. He is also a co-founder of the Psyon clinic – the first European facility to offer a ketamine-assisted therapy to treat mental illnesses. In his clinical profession, his expertise is in basic psychiatry.
Neuroscientist, neurologist, and the head of application of the brain’s electrophysiology research programme at the National Institute of Mental Health (NIMH). He focuses on applying neuromonitoring methods, especially quantitative electroencephalography, during the review of psychoactive substances’ effect on the central nervous system, with the aim of predicting the patient’s reaction to psychopharmacological treatment. He is a co-founder of the Psyon clinic.
Společnost pro podporu neurovědního výzkumu s.r.o.,
V Honech 687, 250 67 Klecany, IČO: 05547130
Economist and philanthropist, investor in financial and private equity projects at RSJ, co-owner of the Dox Prague Center for Contemporary Art and documentary film producer. He likes to deal with disruptive thoughts and is convinced in the fundamental societal significance of the psychedelic renaissance.
Lifelong adventurer and businessman. He traveled around the world with his backpack, founded several companies (the best known is Mall.cz) and, through his investment fund Reflex Capital, invests in promising Czech projects and entrepreneurs. He and his wife Tereza are raising three children and support a number of non-profit activities with a social impact.
Multidisciplinary creator, founder and CEO of JAD Production. Dancer, choreographer, director, producer, actor, and one of the most sought after creatives in his field. He has built an extensive list of clients and produces custom projects and brands including Kanye West.
A bioorganic chemist, who has been trained in forensic toxicology and neuropsychopharmacological research for more than 10 years. In the field of psychedelic substances he has a focus on the synthesis of pure alkaloids, their metabolism, and pharmacological characteristics with the potential to their use in psychiatric practice. He is an active member of the International Forensic Toxicological Society and tries to transpose current scientific knowledge into legal narcotics and psychotropic substances.
He received a medical specialization in hygiene and epidemiology in 2000. In 2013, he finished a preventive medicine doctorate at 1.FM UK in Prague. Since 2018 he has been named a docent of the Department of Addictology, 1.FM UK in Prague. From 2002 to 2021, he was the head of the National Monitoring Centre for Drugs and Addiction which is a part of the Reitox network of focal points coordinated by the European Monitoring Centre for Drugs and Addiction. He has published many scientific and concept works in the field of epidemiology of legal and illegal drugs and gambling.
A psychologist who specializes in Psychedelic Harm Reduction and Integration. He is the co-founder of Fluence (www.fluence8.com), a psychedelic education company training mental health providers in psychedelic treatments. Dr. Gorman is also site co-principal investigator and therapist of Phase 2 & 3 clinical trials of MDMA-assisted Psychotherapy for Post-Traumatic Stress Disorder (www.mdmaptsd.org).
A psychologist who specializes in Gestalt Psychotherapy at the CSTG in Milan and as a complementary therapist in Switzerland, deepening the study and practice of bio-natural disciplines. Her field research is carried out in South America in indigenous communities by studying traditional medicines, plants, and healing rituals. In recent years, she has focused her research interests on the use of "master plants" in the therapeutic field in collaboration with universities and research centers in Europe, the United States, and South America. In Italy she promotes the therapeutic use of psychotropic substances in collaboration with the Luca Coscioni Association of which she is a Councilor.
Professor of Psychopharmacology and Behavioral Toxicology, University of Maastricht (Netherlands). He is engaged in research in the field of psychopharmacology, addiction, drugs, and traffic psychology.
Sign up for news about our activities and psychedelic research!